These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 26596543)

  • 21. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.
    Makino Y; Yamanoi A; Kimoto T; El-Assal ON; Kohno H; Nagasue N
    Am J Gastroenterol; 2000 May; 95(5):1294-300. PubMed ID: 10811342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis.
    Khajeh E; Aminizadeh E; Moghadam AD; Ramouz A; Klotz R; Golriz M; Merle U; Springfeld C; Chang DH; Longerich T; Büchler MW; Mehrabi A
    Cancer Med; 2023 Oct; 12(19):19548-19559. PubMed ID: 37737550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of menopausal status on the survival and recurrence of sex-classified hepatocellular carcinoma after liver resection: a case-matched study with propensity score matching.
    Zhang W; Liu F; Huang J; Guo X; Dong W; Wei S; Li L; Zhu X; Zhou W; Liu H
    Aging (Albany NY); 2020 Nov; 12(24):25895-25915. PubMed ID: 33232278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis.
    Wada H; Eguchi H; Nagano H; Kubo S; Nakai T; Kaibori M; Hayashi M; Takemura S; Tanaka S; Nakata Y; Matsui K; Ishizaki M; Hirokawa F; Komeda K; Uchiyama K; Kon M; Doki Y; Mori M
    Surg Today; 2018 Jan; 48(1):73-79. PubMed ID: 28597349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicentre study of the prognostic impact of preoperative bodyweight on long-term prognosis of hepatocellular carcinoma.
    Yu JJ; Shen F; Chen TH; Liang L; Han J; Xing H; Zhou YH; Wang H; Gu WM; Lau WY; Yang T
    Br J Surg; 2019 Feb; 106(3):276-285. PubMed ID: 30199100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.
    Takahara T; Wakabayashi G; Beppu T; Aihara A; Hasegawa K; Gotohda N; Hatano E; Tanahashi Y; Mizuguchi T; Kamiyama T; Ikeda T; Tanaka S; Taniai N; Baba H; Tanabe M; Kokudo N; Konishi M; Uemoto S; Sugioka A; Hirata K; Taketomi A; Maehara Y; Kubo S; Uchida E; Miyata H; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):721-7. PubMed ID: 26096910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anatomical versus non-anatomical resection for hepatocellular carcinoma.
    Marubashi S; Gotoh K; Akita H; Takahashi H; Ito Y; Yano M; Ishikawa O; Sakon M
    Br J Surg; 2015 Jun; 102(7):776-84. PubMed ID: 25847111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver resection versus microwave ablation for solitary and small (≤ 3 cm) HCC with early recurrence in different stages of liver cirrhosis: A propensity score matching study.
    Zhu RH; Huang Z; Xie ZH; Yuan T; Li J; Wang WQ; Lv X; Wang JL; Huang ZY; Zhang EL
    Asian J Surg; 2024 Jul; 47(7):3007-3014. PubMed ID: 38342723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
    Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
    Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion.
    Zhang H; Yuan SX; Dai SY; Zhang JM; Huang X; Lu CD; Lu JH; Wu FQ; Lau WY; Wu MC; Yang T; Shen F
    World J Surg; 2014 Apr; 38(4):947-57. PubMed ID: 24258262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in Child-Pugh class A patients.
    Harada N; Shirabe K; Maeda T; Kayashima H; Ishida T; Maehara Y
    World J Surg; 2015 Apr; 39(4):1044-51. PubMed ID: 25446481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis.
    Xing H; Sun LY; Yan WT; Quan B; Liang L; Li C; Zhou YH; Wang H; Zhong JH; Gu WM; Chen TH; Wang MD; Wu H; Pawlik TM; Lau WY; Wu MC; Shen F; Yang T
    Surgery; 2021 Apr; 169(4):911-920. PubMed ID: 31879090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching.
    Wu Z; Tang H; Wang L; Jin X; Lei Z; Yang P; Zhou J
    BMC Surg; 2022 Mar; 22(1):103. PubMed ID: 35313836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma.
    Yang T; Liu K; Liu CF; Zhong Q; Zhang J; Yu JJ; Liang L; Li C; Wang MD; Li ZL; Wu H; Xing H; Han J; Lau WY; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Zhang YM; Zhang WG; Pawlik TM; Wu MC; Shen F
    Br J Surg; 2019 Aug; 106(9):1228-1236. PubMed ID: 31276196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis.
    Zhang YF; Le Y; Wei W; Zou RH; Wang JH; OuYang HY; Xiao CZ; Zhong XP; Shi M; Guo RP
    Oncotarget; 2016 Jun; 7(25):38845-38856. PubMed ID: 27072577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic liver re-resection is feasible for patients with posthepatectomy hepatocellular carcinoma recurrence: a propensity score matching study.
    Liu K; Chen Y; Wu X; Huang Z; Lin Z; Jiang J; Tan W; Zhang L
    Surg Endosc; 2017 Nov; 31(11):4790-4798. PubMed ID: 28389803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection.
    Yamamura K; Sugimoto H; Kanda M; Yamada S; Nomoto S; Nakayama G; Fujii T; Koike M; Fujiwara M; Kodera Y
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):682-8. PubMed ID: 24823966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.